opioid crisis

News

Teva gets its US opioid settlement over the finish line

After years of legal horse-trading, Teva looks like it has finally finalised a settlement that should allow it to put litigation over its role in fuelling the US opioid ep

News

FDA clears nasal opioid reversal drug, lifting Indivior

The FDA has approved a new intranasal therapy for treating opioid overdose developed by Opiant Pharma, giving a boost to its new UK owner Indivior.

News

FDA clears first OTC Narcan spray for opioid overdose

With the US still battling the opioid epidemic, the most widely-used overdose reversal agent – Emergent BioSolutions’ Narcan – can now be bought over the counter at pharma

Patients

The rise of prescription drug abuse and drug diversion

As prescription drug abuse has grown in the US and Europe, the diversion of such treatments from legitimate sources has also increased.

News

New HHS rule would harmonise substance abuse privacy rule, H...

The US Department of Health and Human Services issued a new proposed rule Monday that would change how privacy protections for people with substance abuse disorders interact with HIPAA info

News

Walmart offers $3.1bn to settle opioid epidemic lawsuits

Walmart has become the latest big pharmacy chain in the US to put forward a settlement to resolve claims it contributed to the national opioid crisis by failing to regulate prescriptions at

Teva gets its US opioid settlement over the finish line

FDA clears nasal opioid reversal drug, lifting Indivior

FDA clears first OTC Narcan spray for opioid overdose

The rise of prescription drug abuse and drug diversion

New HHS rule would harmonise substance abuse privacy rule, H...

Walmart offers $3.1bn to settle opioid epidemic lawsuits

Vaxcyte's pneumococcal jab exceeds expectations

Discover a new era of healthcare panel engagement: Grounded ...

opioid crisis

Editor's Picks